GeneDx Holdings Financial Overview
GeneDx Holdings's market cap is currently $4.06B. The company's EPS TTM is $0.49; its P/E ratio is 2,324.54; GeneDx Holdings is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
